Marinela Capanu, Ph.D.

Affiliations: 
2005 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Statistics
Google:
"Marinela Capanu"

Parents

Sign in to add mentor
Brett Presnell grad student 2005 UF Gainesville
 (Tests of misspecification for parametric models.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Capanu M, Giurcanu M, Begg CB, et al. (2023) Subsampling based variable selection for generalized linear models. Computational Statistics & Data Analysis. 184
El Dika I, Capanu M, Chou JF, et al. (2020) Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. Cancer Medicine
Yaeger R, Paroder V, Bates DDB, et al. (2020) Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis. Clinical Colorectal Cancer
McIntyre CA, Lawrence SA, Richards AL, et al. (2020) Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. Cancer
Harding JJ, Kelley RK, Tan B, et al. (2020) Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. The Oncologist
Janjigian YY, Maron SB, Chatila WK, et al. (2020) First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial. The Lancet. Oncology
El Dika I, Mayer RJ, Venook AP, et al. (2020) A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. The Oncologist
Capanu M, Giurcanu M, Begg CB, et al. (2020) Optimized variable selection via repeated data splitting. Statistics in Medicine
O'Reilly EM, Lee JW, Zalupski M, et al. (2020) Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline Mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902931
van Beek EJAH, Hernandez JM, Goldman DA, et al. (2020) Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. Annals of Surgical Oncology
See more...